Sinphar Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
March 28, 2019 at 05:11 pm EDT
Share
Sinphar Pharmaceutical Co. Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 2,215.837 million compared to TWD 2,134.163 million a year ago. Operating loss was TWD 119.296 million compared to TWD 63.027 million a year ago. Net income was TWD 8.785 million compared to TWD 36.726 million a year ago. Basic earnings per share was TWD 0.05 compared to TWD 0.22 a year ago.
Sinphar Pharmaceutical Co., Ltd. is principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company is also engaged in the sales of functional food products. The Companyâs principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The Company mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
SINPHAR PHARMACEUTICAL CO.,LTD. 
